Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?

Environmental Health Perspectives

Volumn 120, Issue 3, 2012, Pages 332-339

  Snedeker, Suzanne M ^a   Hay, Anthony G ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

ADME; Biotransformation enzymes; Diabetes mellitus; Diabetogenic; Environmental chemicals; Gut ecology; Metabolic syndrome; Microbes; Microbiota; Obesity; Obesogen; Obesogenic; Persistent organic pollutants; POPs

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4,4' ISOPROPYLIDENEDIPHENOL; ALACHLOR; CHLORDANE; CHLORPYRIFOS; CYANAZINE; DIETHYLSTILBESTROL; DIMPYLATE; DIOXIN; ENVIRONMENTAL CHEMICAL; ESTROGEN RECEPTOR; GENISTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID RECEPTOR; HEPTACHLOR; HERBICIDE; HEXACHLOROBENZENE; INSECTICIDE; METRIFONATE; NONYLPHENOL; PEPTIDE YY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; TRIBUTYLTIN;

BARIATRIC SURGERY; BIOTRANSFORMATION; BODY FAT; DIABETES MELLITUS; DIET; DISEASE RESISTANCE; ENDOTOXEMIA; ENTEROHEPATIC CIRCULATION; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FOOD INTAKE; GLYCEMIC CONTROL; HUMAN; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BYPASS; INTESTINE FLORA; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; METABOLIC SYNDROME X; MICROBIAL METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOXICOKINETICS; WEIGHT GAIN;

ANIMALS; DIABETES MELLITUS; ENVIRONMENTAL POLLUTANTS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MICE; OBESITY; RATS; XENOBIOTICS;

ANIMALIA;

EID: 84857726895     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104204     Document Type: Review

References (162)

1. Ahima RS, Sabri A. 2011. Bariatric surgery: metabolic benefits beyond weight loss. Gastroenterology 141(3):793-795.
2. Antizar-Ladislao B. 2008. Environmental levels, toxicity and human exposure to tributyltin (TBT)-contaminated marine environment. Environ Int 34(2):292-308.
3. Appel KE. 2004. Organotin compounds: toxicokinetic aspects. Drug Metab Rev 36(3-4):763-786.
4. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLOS One 4(9):e7125; doi:10.1371/journal.pone.0007125 [Online 23 September 2009].
5. Arumugam M, Raes J, Pelletier E, LE Paslier D, Yamada T, Mende DR, etal. 2011. Enterotypes of the human gut microbiome. Nature 473(7346):174-180.
6. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, etal. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718-15723.
7. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104(3):979-984.
8. Baillie-Hamilton PF. 2002. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8(2):185-192.
9. Bjorneklett A, Viddal KO, Midtvedt T, Nygaard K. 1981. Intestinal and gastric bypass. Changes in intestinal microecology after surgical treatment of morbid obesity in man. Scand J Gastroenterol 16(5):681-687.
10. Boberg J, Metzdorff S, Wortziger R, Axelstad M, Brokken L, Vinggaard AM, etal. 2008. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 250(2-3):75-81.
11. Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. 2006. Increased intestinal permeability precedes clinical onset of type1 diabetes. Diabetologia 49(12):2824-2827.
12. Cai L, Lubitz J, Flegal KM, Pamuk ER. 2010. The predicted effects of chronic obesity in middle age on Medicare costs and mortality. Med Care 48(6):510-517.
13. Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M, etal. 2010. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 34:1095-1098; doi:10.1038/ijo.2010.44. [Online 9 March 2010].
14. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, etal. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470-1481.
15. Cani PD, Delzenne NM. 2007. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10(6):729-734.
16. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, etal. 2009. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90(5):1236-1243.
17. Carpenter DO. 2008. Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 23(1):59-74.
18. Casals-Casas C, Desvergne B. 2011. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73:135-162.
19. Casals-Casas C, Feige JN, Desvergne B. 2008. Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes (Lond) 32 (suppl 6):S53-S61; doi:10.1038/ijo.2008.207 [Online 23 December 2008].
20. Cawley J, Meyerhoefer C. 2010. The Medical Care Costs of Obesity: An Instrumental Variables Approach. (National Bureau of Economic Research Working Paper Series, NBER Working Paper No 16467). Cambridge, MA:National Bureau of Economic Research.
21. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, etal. 2007. Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222(3):298-304.
22. Claus SP, Ellero SL, Berger JP, Krause L, Bruttin A, Molina J, et al. 2011. Colonization-induced host-gut microbial metabolic interaction. m Bio 2(2); doi:10.1128/m Bio.00271-10 [Online 1 March 2011].
23. Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. 2009. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 106(34):14728-14733.
24. Codru N, Schymura MJ, Negoita S, Rej R, Carpenter DO. 2007. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 115:1442-1447.
25. Collado MC, Isolauri E, Laitinen K, Salminen S. 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88(4):894-899.
26. Collado MC, Isolauri E, Laitinen K, Salminen S. 2010. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr 95(2):1023-1030.
27. Coronado-Gonzalez JA, Del Razo LM, Garcia-Vargas G, Sanmiguel-Salazar F, Escobedo-de la Pena J. 2007. Inorganic arsenic exposure and type2 diabetes mellitus in Mexico. Environ Res 104(3):383-389.
28. Cox S, Niskar AS, Narayan KM, Marcus M. 2007. Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Hispanic Health and Nutrition Examination Survey, 1982-1984. Environ Health Perspect 115:1747-1752.
29. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, etal. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31-40; doi:10.1016/S0140-6736(11)60679-X [Online 24 June 2011].
30. Dean JR, Ma R. 2007. Approaches to assess the oral bioaccessibility of persistent organic pollutants: a critical review. Chemosphere 68(8):1399-1407.
31. Di Pietro G, Magno LA, Rios-Santos F. 2010. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 6(2):153-170.
32. Diaz-Villasenor A, Burns AL, Hiriart M, Cebrian ME, Ostrosky-Wegman P. 2007. Arsenic-induced alteration in the expression of genes related to type2 diabetes mellitus. Toxicol Appl Pharmacol 225(2):123-133.
33. Diaz-Villasenor A, Sanchez-Soto MC, Cebrian ME, Ostrosky-Wegman P, Hiriart M. 2006. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol 214(1):30-34.
34. Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, Mainous AG, III. 2007. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 103(3):413-418.
35. Everett CJ, Matheson EM. 2010. Biomarkers of pesticide exposure and diabetes in the 1999-2004 National Health and Nutrition Examination Survey. Environ Int 36(4):398-401.
36. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, etal. 2010. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARa-dependent mechanisms. Environ Health Perspect 118:234-241.
37. Fenton SE, Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Hines EP, etal. 2009. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod Toxicol 27(3-4):365-372.
38. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. 2009. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28(5):w822-w831.
39. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, etal. 2011. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377(9765):557-567.
40. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. 1998. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22(1):39-47.
41. Flegal KM, Carroll MD, Ogden CL, Curtin LR. 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303(3):235-241.
42. Fleissner CK, Huebel N, Abd El-Bary MM, Loh G, Klaus S, Blaut M. 2010. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104(6):919-929.
43. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59(12):3049-3057.
44. Garcia-Lafuente A, Antolin M, Guarner F, Crespo E, Malagelada JR. 2001. Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut 48(4):503-507.
45. Genuis SJ. 2011. Elimination of persistent toxicants from the human body. Hum Exp Toxicol 30(1):3-18.
46. Goodman AL, Gordon JI. 2010. Our unindicted coconspirators: human metabolism from a microbial perspective. Cell Metab 12(2):111-116.
47. Grün F. 2010. Obesogens. Curr Opin Endocrinol Diabetes Obes 17(5):453-459.
48. Grün F, Blumberg B. 2006. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6 suppl):S50-S55.
49. Grün F, Blumberg B. 2007. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8(2):161-171.
50. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20(9):2141-2155.
51. Grundmann O. 2010. The gut microbiome and pre-systemic metabolism: current state and evolving research. J Drug Metabol Toxicol 1:104; doi:10.4172/2157-7609.1000104 [Online 30 November 2010].
52. Hallstrom M, Eerola E, Vuento R, Janas M, Tammela O. 2004. Effects of mode of delivery and necrotising enterocolitis on the intestinal microflora in preterm infants. Eur J Clin Microbiol Infect Dis 23(6):463-470.
53. Hansen EE, Lozupone CA, Rey FE, Wu M, Guruge JL, Narra A, et al. 2011. Pan-genome of the dominant human gut-associated archaeon, Methanobrevibacter smithii, studied in twins. Proc Natl Acad Sci USA 108(suppl 1):4599-4606.
54. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, etal. 2008. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7:27; doi:10.1186/1476-069X-7-27 [Online 3 June 2008].
55. Heindel JJ, vom Saal FS. 2009. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 304(1-2):90-96.
56. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. 1997. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8(3):252-258.
57. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE. 2009. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304(1-2):97-105.
58. Howard SG, Lee DH. 2011. What is the role of human contamination by environmental chemicals in the development of type1 diabetes? J Epidemiol Community Health; doi:10.1136/jech.2011.133694 [Online 17 April 2011].
59. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. 2008. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116:1642-1647.
60. Humblot C, Murkovic M, Rigottier-Gois L, Bensaada M, Bouclet A, Andrieux C, etal. 2007. Beta-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Carcinogenesis 28(11):2419-2425.
61. Inadera H, Shimomura A. 2005. Environmental chemical tributyltin augments adipocyte differentiation. Toxicol Lett 159(3):226-234.
62. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, etal. 2011. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94(1):58-65.
63. Kalliomaki M, Collado MC, Salminen S, Isolauri E. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87(3):534-538.
64. Kang HK, Dalager NA, Needham LL, Patterson DG Jr, Lees PS, Yates K, etal. 2006. Health status of Army Chemical Corps Vietnam veterans who sprayed defoliant in Vietnam. Am J Ind Med 49(11):875-884.
65. Kannan K, Takahashi S, Fujiwara N, Mizukawa H, Tanabe S. 2010. Organotin compounds, including butyltins and octyltins, in house dust from Albany, New York, USA. Arch Environ Contam Toxicol 58(4):901-907.
66. Kemperman RA, Bolca S, Roger LC, Vaughan EE. 2010. Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 156(Pt 11):3224-3231.
67. Kim Y, Lee BK. 2011. Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES 2008. Sci Total Environ 409(19):4054-4062.
68. Kirchner S, Kieu T, Chow C, Casey S, Blumberg B. 2010. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 24(3):526-539.
69. Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, etal. 2011. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab; doi:10.1111/j.1463-1326.2011.01483.x [Online 22 November 2011].
70. La Merrill M, Birnbaum LS. 2011. Childhood obesity and environmental chemicals. Mt Sinai J Med 78(1):22-48.
71. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, etal. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300(11):1303-1310.
72. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, etal. 2010. Gut microbiota in human adults with type2 diabetes differs from non-diabetic adults. PLOS One 5(2):e9085; doi:10.1371/journal.pone.0009085 [Online 5 February 2010].
73. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR Jr. 2007a. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30(3):622-628.
74. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR Jr. 2007b. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50(9):1841-1851.
75. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. 2006. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 29(7):1638-1644.
76. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr. 2010. Low dose of some persistent organic pollutants predicts type2 diabetes: a nested case-control study. Environ Health Perspect 118:1235-1242.
77. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr. 2011. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLOS One 6(1):e15977; doi:10.1371/journal.pone.0015977 [Online 26 January 2011].
78. Lee MJ, Lin H, Liu CW, Wu MH, Liao WJ, Chang HH, etal. 2008. Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways. Am J Physiol Cell Physiol 294(6):C1542-C1551.
79. Letran SE, Lee SJ, Atif SM, Flores-Langarica A, Uematsu S, Akira S, etal. 2011. TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. J Immunol 186(9):5406-5412.
80. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070-11075.
81. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022-1023.
82. Lhoste EF, Ouriet V, Bruel S, Flinois JP, Brezillon C, Magdalou J, etal. 2003. The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 41(5):695-702.
83. Like AA, Rossini AA. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193(4251):415-417.
84. Lim JS, Lee DH, Jacobs DR Jr. 2008. Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care 31(9):1802-1807.
85. Lopez-Espinosa MJ, Freire C, Arrebola JP, Navea N, Taoufiki J, Fernandez MF, etal. 2009. Nonylphenol and octylphenol in adipose tissue of women in Southern Spain. Chemosphere 76(6):847-852.
86. Lundin JI, Alexander BH, Olsen GW, Church TR. 2009. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20(6):921-928.
87. MacNeil J, Steenland NK, Shankar A, Ducatman A. 2009. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109(8):997-1003.
88. McBain AJ, MacFarlane GT. 1998. Ecological and physiological studies on large intestine bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 47(5):407-416.
89. Meijer L, Hafkamp AM, Bosman WE, Havinga R, Bergman A, Sauer PJ, etal. 2006. Nonabsorbable dietary fat enhances disposal of 2,2',4,4'-tetrabromodiphenyl ether in rats through interruption of enterohepatic circulation. J Agric Food Chem 54(17):6440-6444.
90. Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serne EH, Smulders YM. 2011. Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg 146(6):744-750.
91. Meinl W, Sczesny S, Brigelius-Flohe R, Blaut M, Glatt H. 2009. Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos 37(6):1179-1186.
92. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. 2010. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLOS One 5(1):e8673; doi:10.1371/journal.pone.0008673 [Online 13 January 2010].
93. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, etal. 2008. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22(7):2416-2426.
94. Merali Z, Singhal RL. 1980. Diabetogenic effects of chronic oral cadmium adminstration to neonatal rats. Br J Pharmacol 69(1):151-157.
95. Michalek JE, Pavuk M. 2008. Diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia. J Occup Environ Med 50(3):330-340.
96. Miyawaki J, Sakayama K, Kato H, Yamamoto H, Masuno H. 2007. Perinatal and postnatal exposure to bisphenol A increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 14(5):245-252.
97. Montgomery MP, Kamel F, Saldana TM, Alavanja MC, Sandler DP. 2008. Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003. Am J Epidemiol 167(10):1235-1246.
98. Muegge BD, Kuczynski J, Knights D, Clemente JC, Gonzalez A, Fontana L, etal. 2011. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332(6032):970-974.
99. Musso G, Gambino R, Cassader M. 2010. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33(10):2277-2284.
100. Musso G, Gambino R, Cassader M. 2011. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62:361-380.
101. Myers MA, Hettiarachchi KD, Ludeman JP, Wilson AJ, Wilson CR, Zimmet PZ. 2003. Dietary microbial toxins and type1 diabetes. Ann N Y Acad Sci 1005:418-422.
102. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. 2006. Arsenic exposure and type2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 114:641-648.
103. Neu J, Lorca G, Kingma SD, Triplett EW. 2010. The intestinal microbiome: relationship to type1 diabetes. Endocrinol Metab Clin North Am 39(3):563-571.
104. Newbold RR. 2010. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 9(3):206-217.
105. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. 2008. Effects of endocrine disruptors on obesity. Int J Androl 31(2):201-208.
106. Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN. 2007. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23(3):290-296.
107. Oishi K, Sato T, Yokoi W, Yoshida Y, Ito M, Sawada H. 2008. Effect of probiotics, Bifidobacterium breve and Lactobacillus casei, on bisphenol A exposure in rats. Biosci Biotechnol Biochem 72(6):1409-1415.
108. Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, etal. 2009. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health 8:37; doi:10.1186/1476-069X-8-37 [Online 18 August 2009].
109. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2):511-521.
110. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. 2005. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243(1):141-147.
111. Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, Tanini A, etal. 2006. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147(12):5740-5751.
112. Peters WH, Kock L, Nagengast FM, Kremers PG. 1991. Biotransformation enzymes in human intestine: critical low levels in the colon? Gut 32(4):408-412.
113. Pinyayev TS, Kohan MJ, Herbin-Davis K, Creed JT, Thomas DJ. 2011. Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem Res Toxicol 24(4):475-477.
114. Possemiers S, Grootaert C, Vermeiren J, Gross G, Marzorati M, Verstraete W, etal. 2009. The intestinal environment in health and disease-recent insights on the potential of intestinal bacteria to influence human health. Curr Pharm Des 15(18):2051-2065.
115. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59-65.
116. Rabot S, Membrez M, Bruneau A, Gerard P, Harach T, Moser M, etal. 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 24(12):4948-4959.
117. Rahman MM, Ng JC, Naidu R. 2009. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31 (suppl 1):189-200.
118. Ravussin Y, Koren O, Spor A, Leduc C, Gutman R, Stombaugh J, etal. 2011. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring); doi:10.1038/oby.2011.111 [Online 19 May 2011].
119. Reddy BS, Pleasants JR, Wostmann BS. 1973. Metabolic enzymes in liver and kidney of the germfree rat. Biochim Biophys Acta 320(1):1-8.
120. Reed MA, Pories WJ, Chapman W, Pender J, Bowden R, Barakat H, etal. 2011. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab 96(8):2525-2531.
121. Rignell-Hydbom A, Lidfeldt J, Kiviranta H, Rantakokko P, Samsioe G, Agardh CD, etal. 2009. Exposure to p, p'-DDE: a risk factor for type2 diabetes. PLOS One 4(10):e7503; doi:10.1371/journal.pone.0007503 [Online 19 October 2009].
122. Rowland IR. 2009. The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des 15(13):1524-1527.
123. Rowland IR, Mallett AK, Bearne CA, Farthing MJ. 1986. Enzyme activities of the hindgut microflora of laboratory animals and man. Xenobiotica 16(6):519-523.
124. Rowland IR, Mallett AK, Wise A. 1985. The effect of diet on the mammalian gut flora and its metabolic activities. Crit Rev Toxicol 16(1):31-103.
125. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. 2001. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 109:675-680.
126. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ. 2010. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 151(6):2603-2612.
127. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N, etal. 2004. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141(2):209-214.
128. Sanz Y, Santacruz A, Gauffin P. 2010. Probiotics in the defence and metabolic balance of the organism: Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 69:434-441.
129. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. 2010. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18(7):1283-1288; doi:10.1038/oby.2009.419 [Online 19 November 2009].
130. Schauer PR, Rubino F. 2011. International Diabetes Federation position statement on bariatric surgery for type2 diabetes: implications for patients, physicians, and surgeons. Surg Obes Relat Dis 7(4):448-451.
131. Schwartz GG, Il'yasova D, Ivanova A. 2003. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 26(2):468-470.
132. Son HK, Kim SA, Kang JH, Chang YS, Park SK, Lee SK, etal. 2010. Strong associations between low-dose organochlorine pesticides and type2 diabetes in Korea. Environ Int 36(5):410-414.
133. Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. 2008. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 363(1-2):1-25.
134. Tam CS, Berthoud HR, Bueter M, Chakravarthy MV, Geliebter A, Hajnal A, etal. 2011. Could the mechanisms of bariatric surgery hold the key for novel therapies?: a report from the Pennington Scientific Symposium. Obes Rev; doi:10.1111/j.1467-789X.2011.00902.x [Online 6 July 2011].
135. Teubner W, Meinl W, Florian S, Kretzschmar M, Glatt H. 2007. Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404(2):207-215.
136. Treptow-van Lishaut S, Rechkemmer G, Rowland I, Dolara P, Pool-Zobel BL. 1999. The carbohydrate crystalean and colonic microflora modulate expression of glutathione S-transferase subunits in colon of rats. Eur J Nutr 38(2):76-83.
137. Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, et al. 2007. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121(2):356-360.
138. Tseng CH. 2007. Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans. J Environ Biol 28(2 suppl):349-357.
139. Turnbaugh PJ, Gordon JI. 2009. The core gut microbiome, energy balance and obesity. J Physiol 587(Pt 17):4153-4158.
140. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, etal. 2009a. A core gut microbiome in obese and lean twins. Nature 457(7228):480-484.
141. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027-1031.
142. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, etal. 2010. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA 107(16):7503-7508.
143. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009b. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14.
144. Turyk M, Anderson H, Knobeloch L, Imm P, Persky V. 2009a. Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect 117:1076-1082.
145. Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW. 2009b. Prevalence of diabetes and body burdens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p, p'-diphenyldichloroethene in Great Lakes sport fish consumers. Chemosphere 75(5):674-679.
146. Ukropec J, Radikova Z, Huckova M, Koska J, Kocan A, Sebokova E, etal. 2010. High prevalence of prediabetes and diabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 53(5):899-906.
147. Van de Wiele T, Gallawa CM, Kubachka KM, Creed JT, Basta N, Dayton EA, etal. 2010. Arsenic metabolism by human gut microbiota upon invitro digestion of contaminated soils. Environ Health Perspect 118:1004-1009.
148. Van de Wiele T, Vanhaecke L, Boeckaert C, Peru K, Headley J, Verstraete W, etal. 2005. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect 113:6-10.
149. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJJ, Gross G, etal. 2010. Microbes and Health Sackler Colloquium: Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci USA 108 (suppl 1):4531-4538.
150. Vehik K, Dabelea D. 2011. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 27(1):3-13.
151. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, etal. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328(5975):228-231.
152. Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330(6005):831-835.
153. Wang SL, Tsai PC, Yang CY, Leon Guo Y. 2008. Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 31(8):1574-1579.
154. Wang Y, Lobstein T. 2006. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1(1):11-25.
155. Wang YC, Gortmaker SL, Taveras EM. 2011. Trends and racial/ethnic disparities in severe obesity among US children and adolescents, 1976-2006. Int J Pediatr Obes 6(1):12-20.
156. Wiegand H, Boesch-Saadatmandi C, Regos I, Treutter D, Wolffram S, Rimbach G. 2009. Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats. Nutr Cancer 61(5):717-722.
157. Wilson ID. 2009. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci USA 106(34):14187-14188.
158. Wilson ID, Nicholson JK. 2009. The role of gut microbiota in drug response. Curr Pharm Des 15(13):1519-1523.
159. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, etal. 2008. Environmental exposures and puberty in inner-city girls. Environ Res 107(3):393-400.
160. Yen CC, Lu FJ, Huang CF, Chen WK, Liu SH, Lin-Shiau SY. 2007. The diabetogenic effects of the combination of humic acid and arsenic: in vitro and in vivo studies. Toxicol Lett 172(3):91-105.
161. Zhang H, Di Baise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, etal. 2009. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106(7):2365-2370.
162. Zuo Z, Chen S, Wu T, Zhang J, Su Y, Chen Y, etal. 2011. Tributyltin causes obesity and hepatic steatosis in male mice. Environ Toxicol 26(1):79-85.